Table 2.
F0 (36) | F1 (11) | F2 (14) | F3 (20) | F4 (38) | Differences | |
Sex, n (%) | ||||||
Men | 10 (30) | 6 (60) | 7 (50) | 9 (45) | 13 (37) | N/A |
Women | 26 (70) | 5 (40) | 7 (50) | 11 (55) | 25 (63) | N/A |
Age in yr | 50 ± 12 | 39 ± 7 | 55 ± 13 | 59 ± 10 | 55 ± 13 | F0-F1a, F0-F3a, F1-F2b, F1-F3b, F1-F4b |
BMI in kg/m2 | 25 ± 4 | 26 ± 4 | 26 ± 3 | 27 ± 3 | 27 ± 5 | F0-F4a |
Hb in g/dL | 15.0 ± 1.3 | 14.0 ± 2.0 | 14.0 ± 2.0 | 14.0 ± 2.0 | 14.0 ± 2.0 | N/S |
Leu in g/dL | 5.6 ± 1.3 | 6.5 ± 0.8 | 4.2 ± 1.4 | 4.7 ± 1.2 | 4.3 ± 2.2 | F0-F4b |
Platelets as × 103 | 231 ± 56 | 233 ± 20 | 193 ± 74 | 163 ± 54 | 92 ± 39 | F0-F3b |
F0-F4b | ||||||
F1-F4b | ||||||
F2-F4b | ||||||
F3-F4b | ||||||
Total bilirubin in mg/dL | 0.72 ± 0.31 | 0.44 ± 0.22 | 0.73 ± 0.28 | 1.75 ± 0.85 | 2.39 ± 2.7 | F0-F1b |
F1-F4b | ||||||
F2-F4a | ||||||
F3-F4a | ||||||
Direct bilirubin in mg/dL | 0.18 ± 0.10 | 0.07 ± 0.05 | 0.12 ± 0.10 | 0.23 ± 0.15 | 0.27 ± 0.3 | F0-F1a |
AST in UI/L | 45 ± 7 | 38 ± 12 | 49 ± 11 | 74 ± 10 | 86 ± 16 | F0-F3b |
F0-F4b | ||||||
F1-F3a | ||||||
F1-F4a | ||||||
ALT in UI/L | 56 ± 11 | 56 ± 8 | 57 ± 10 | 69 ± 10 | 80 ± 13 | F0-F4b |
GGT in UI/L | 70.49 ± 15.65 | 51.30 ± 19.43 | 52.62 ± 14.10 | 91.58 ± 18.74 | 144.00 ± 25.29 | F0-F4a |
F1-F3a | ||||||
F1-F4b | ||||||
F2-F4a |
P < 0.05.
P < 0.01. Data are expressed as the mean ± standard deviation. Fibrosis stages: F0, F1, F2, F3 and F4. ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BMI: Body mass index, GGT: Gamma glutamyl transpeptidase; Hb: Hemoglobin; Leu: Leukocytes; N/A: Not applicable; N/S: Not significant.